PETROLATUM for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 15 adverse event reports in the FDA FAERS database where PETROLATUM was used for Psoriasis.
Most Reported Side Effects for PETROLATUM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 86 | 24.4% | 3 | 12 |
| Rash | 31 | 8.8% | 3 | 12 |
| Pruritus | 25 | 7.1% | 3 | 11 |
| Condition aggravated | 20 | 5.7% | 2 | 6 |
| Erythema | 20 | 5.7% | 3 | 8 |
| Drug hypersensitivity | 16 | 4.6% | 3 | 4 |
| Off label use | 16 | 4.6% | 4 | 7 |
| Lip swelling | 15 | 4.3% | 0 | 6 |
| Product use in unapproved indication | 13 | 3.7% | 3 | 6 |
| Therapeutic response decreased | 13 | 3.7% | 0 | 0 |
| Coeliac disease | 12 | 3.4% | 0 | 0 |
| Pain | 12 | 3.4% | 1 | 2 |
| Product complaint | 12 | 3.4% | 0 | 0 |
| Skin exfoliation | 12 | 3.4% | 0 | 4 |
| Blister | 11 | 3.1% | 3 | 7 |
Other Indications for PETROLATUM
Product used for unknown indication (81)
Chapped lips (22)
Lip dry (21)
Dry skin (10)
Eczema (10)
Oedema (6)
Skin fissures (6)
Dermatitis diaper (5)
Pruritus (5)
Rash (5)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)